Cardinal (CAH) Is Considered a Good Investment by Brokers: Is That True?

robot
摘要生成中

This article examines brokerage recommendations for Cardinal Health (CAH), noting its average brokerage recommendation (ABR) of 1.25, indicating a “Strong Buy” to “Buy” consensus from 16 firms. However, it cautions against relying solely on these recommendations due to potential positive bias from brokerage firms’ vested interests. Instead, it suggests validating such recommendations with tools like the Zacks Rank, which for CAH is currently a #2 (Buy), driven by positive earnings estimate revisions.

此頁面可能包含第三方內容,僅供參考(非陳述或保證),不應被視為 Gate 認可其觀點表述,也不得被視為財務或專業建議。詳見聲明
  • 讚賞
  • 留言
  • 轉發
  • 分享
留言
請輸入留言內容
請輸入留言內容
暫無留言